Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis. - Guttman-Yassky, Emma; Simpson, Eric; Esfandiari, Ehsanollah; Mano, Hirotaka; Bauer, Jillian; Charuworn, Prista; Kabashima, Kenji (Dermatology & Therapy, 2025)